Scott G. Ginn
Net Worth

Last updated:

What is Scott G. Ginn net worth?

The estimated net worth of Mr. Scott G. Ginn is at least $29,056,741 as of 28 May 2021. He owns shares worth $2,940,009 as insider, has earned $10,256,732 from insider trading and has received compensation worth at least $15,860,000 in Amedisys, Inc..

What is the salary of Scott G. Ginn?

Mr. Scott G. Ginn salary is $1,220,000 per year as Executive Vice President & Chief Financial Officer in Amedisys, Inc..

How old is Scott G. Ginn?

Mr. Scott G. Ginn is 56 years old, born in 1969.

What stocks does Scott G. Ginn currently own?

As insider, Mr. Scott G. Ginn owns shares in one company:

Company Title Shares Price per share Total value
Amedisys, Inc. (AMED) Executive Vice President & Chief Financial Officer 29,109 $101 $2,940,009

What does Amedisys, Inc. do?

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

AMED logo
AMED
Amedisys, Inc.
$101

Scott G. Ginn insider trading

Amedisys, Inc.

Mr. Scott G. Ginn has made 23 insider trades between 2012-2021, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 23,828 units of AMED stock on 8 May 2017. As of 28 May 2021 he still owns at least 29,109 units of AMED stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 975 N/A N/A
Option
Common Stock 975 N/A N/A
Sale
Common Stock 975 N/A N/A
Sale
Common Stock 975 $27.35 $26,666
Option
Common Stock 975 $27.35 $26,666
Option
Stock Option (Right to Buy) 975 $27.35 $26,666
Sale
Common Stock 975 $27.35 $26,666
Option
Common Stock 975 $27.35 $26,666
Option
Stock Option (Right to Buy) 975 $27.35 $26,666
Option
Stock Option (Right to Buy) 975 $27.35 $26,666
Sale
Common Stock 975 $27.35 $26,666
Option
Common Stock 975 $27.35 $26,666
Option
Restricted Stock Unit (Performance-Based Vesting) 2,515 $295.2 $742,428
Option
Common Stock 5,030 N/A N/A
Option
Common Stock 975 $27.35 $26,666
Sale
Common Stock 975 $27.35 $26,666
Option
Stock Option (Right to Buy) 975 $27.35 $26,666
Option
Common Stock 975 $27.35 $26,666
Option
Stock Option (Right to Buy) 975 $27.35 $26,666
Sale
Common Stock 975 $287.57 $280,381
Option
Common Stock 975 $27.35 $26,666
Sale
Common Stock 975 $27.35 $26,666
Option
Stock Option (Right to Buy) 975 $27.35 $26,666
Option
Stock Option (Right to Buy) 975 $27.35 $26,666
Option
Common Stock 975 $27.35 $26,666
Sale
Common Stock 975 $250 $243,750
Sale
Common Stock 975 $27.35 $26,666
Option
Common Stock 975 $27.35 $26,666
Option
Stock Option (Right to Buy) 975 $27.35 $26,666
Option
Common Stock 975 $27.35 $26,666
Sale
Common Stock 975 $27.35 $26,666
Option
Stock Option (Right to Buy) 975 $27.35 $26,666
Option
Common Stock 2,500 N/A N/A
Option
Restricted Stock Unit (Time-Based Vesting) 2,500 N/A N/A
Option
Common Stock 9,000 $27.35 $246,150
Sale
Common Stock 9,000 $176.26 $1,586,322
Option
Stock Option (right to buy) 9,000 $27.35 $246,150
Sale
Common Stock 11,250 $194.03 $2,182,804
Option
Common Stock 11,250 $27.35 $307,688
Option
Stock Option (right to buy) 11,250 $27.35 $307,688
Option
Restricted Stock Unit (Performance-Based Vesting) 3,934 $198.81 $782,119
Option
Common Stock 7,836 N/A N/A
Option
Stock Option (right to buy) 6,049 $37.8 $228,634
Option
Common Stock 6,049 $37.8 $228,634
Sale
Common Stock 7,690 $144.96 $1,114,742
Sale
Common Stock 4,871 $131.5 $640,537
Sale
Common Stock 4,872 $118.5 $577,332
Option
Common Stock 2,500 N/A N/A
Option
Restricted Stock Unit (Time-Based Vesting) 2,500 N/A N/A
Option
Common Stock 8,982 $13.68 $122,829
Option
Common Stock 8,982 $13.68 $122,829
Option
Restricted Stock Unit (Performance-Based Vesting) 1,875 $27.35 $51,281
Option
Stock Option (right to buy) 5,625 $27.35 $153,844
Sale
Common Stock 7,640 $118.28 $903,644
Option
Common Stock 5,625 $27.35 $153,844
Option
Stock Option (right to buy) 3,750 $27.35 $102,563
Sale
Common Stock 7,755 $78.44 $608,302
Option
Common Stock 3,750 $27.35 $102,563
Option
Common Stock 2,500 N/A N/A
Option
Restricted Stock Unit (Time-Based Vesting) 2,500 N/A N/A
Option
Restricted Stock Unit (Performance-Based Vesting) 2,727 $13.68 $37,292
Option
Common Stock 2,727 $13.68 $37,292
Sale
Common Stock 23,828 $58.62 $1,396,797
Option
Common Stock 1,875 $27.35 $51,281
Option
Restricted Stock Unit (Performance-Based Vesting) 1,875 $27.35 $51,281
Sale
Common Stock 6,000 $51.65 $309,900
Option
Restricted Stock Unit 5,247 N/A N/A
Option
Restricted Stock Unit 1,875 N/A N/A
Sale
Common Stock 3,063 $46.33 $141,909
Sale
Common Stock 1,947 $14.37 $27,978
Sale
Common Stock 2,500 $14.37 $35,925
Sale
Common Stock 1,375 $14.36 $19,745

Amedisys key executives

Amedisys, Inc. executives and other stock owners filed with the SEC: